Skip to main content

Table 2 Patients’ clinical data

From: Life disturbance and hospital visit experiences among Chinese patients with benign prostatic hyperplasia: a qualitative study

Variables

N(%)

Disease duration(years)

 

 1–5

20 (43.5)

 6–10

16 (34.8)

 11–15

5 (10.9)

 16–20

4 (8.7)

 > 20

1 (2.2)

IPSS(points)

 

 8–19 (Moderate)

8 (17.4)

 20–35 (Severe)

38 (82.6)

QOL(points)

 

 3 (Mixed)

5 (10.9)

 4 (Mostly dissatisfied)

49 (8.7)

 5 (Unhappy)

24 (52.2)

 6 (Terrible)

13 (28.3)

Comorbidities

 

 Acute urinary retention

17 (37.0)

 Hydronephrosis

3 (6.5)

 Urinary calculi

6 (13.0)

 Urinary infection

7 (15.2)

 Hematuria

4 (8.7)

 No comorbidities

9 (19.6)

  1. IPSS (International Prostate Symptom Score): 0–7, mildly symptomatic; 8–19, moderately symptomatic; 20–35, severely symptomatic
  2. QOL (Quality of Life): 0, delighted; 1, Pleased; 2, Mostly satisfied; 3, Mixed; 4, Mostly dissatisfied; 5, Unhappy; 6, Terrible
Back to article page

BMC Primary Care

ISSN: 2731-4553

Contact us